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BACKGROUND OBJECTIVE
METHODS
CONCLUSIONS
The objective of this  review was to determine  if  there were 
statistically significant differences in maternal and fetal  outcomes 
between diet only and diet  + insulin groups . 
RESULTS
DISCLOSURES
History of Gestational Diabetes Clinic
•Clinic within the Hall County Health Department 
Prenatal Clinic which provides access to 
comprehensive, high quality, affordable prenatal care for 
low-income-uninsured women
•Clinic began in the 1970s in response to increasing 
number of women without prenatal care who presented 
to local hospital for delivery.
•Initially, local physicians donated their time to the clinic 
to work with health department nursing staff to provide 
obstetric care.
•In the late 1980s, midwifery program was added to the 
clinic.
•In the mid 1990s, the gestational diabetes clinic was 
created within the prenatal clinic.  Patients who have 
either gestational or pregestational diabetes receive 
care in this clinic.
•Clinic currently functions as a collaboration of the 
Northeast Georgia Health System, The Longstreet Clinic 
and The Hall County Health Department.
•The percentage of Latinos in this clinic has grown from 
20% in the early 1990s to over 90% currently.
Hall County
•Located in Northeast Georgia, 50 miles 
northeast of Atlanta.
•Population is approximately 187,700.
•In 2007, average household income  was 
$56,358.
•Industry: 24% service, 22.6% manufacturing, 
14.2% government, 11.8% health care.
•Large Latino immigrant population due to strong 
manufacturing industry within the community.
The retrospective chart review  was completed on  160 gestational and 
pregestational Latino  patients receiving care between March 2012  and 
March 2014.   Data was collected  from both paper charts and 
electronic medical records August 2014– May 2015.  
The baseline characteristics and maternal and fetal outcomes 
measured are provided below.
Specific Characteristics or 
Outcomes 
Baseline Characteristics Patient age; ethnicity; BMI at initial
visit; A1c at initial visit; gestational age 
(in weeks) at diagnosis
Maternal Outcomes Rate of caesarean delivery; maternal 
weight gain; hypertension; pre-
eclampsia; maternal glycemic control; 
maternal A1c (at end of pregnancy)
Fetal Outcomes Large for gestational age (birthweight 
> 2 standard deviations (SD); 
macrosomia; birth weight; Apgar score 
at 5 minutes; hypoglycemia; 
premature birth; neonatal jaundice; 
dystocia 
Baseline
Characteristics
Group 1 
(Diet Only) 
(85)
Group 2  
(Diet + 
Insulin) (75)
P - value
Patients (%) 85 (53%) 75 (47%) -
Patient age 
(years of age)
33.04 +/-
5.56
34.49 +/-
5.05
0.086
BMI at initial
visit
31.57 +/-
5.00
34.13 +/-
5.59
0.003*
A1c at initial 
visit (%)
5.69 +/-
0.66
6.658 +/-
1.38
<0.001*
Gestational age 
(in weeks) at 
diagnosis
20.36 +/-
9.14
20.89 +/-
9.33
0.718
Maternal Outcomes Group 1 
(Diet Only) 
(85)
Group 2 
(Diet + 
Insulin) 
(75)
P - value
Caesarean delivery 
(%) 
28 
(32.94%)
38 
(50.67%)
0.089
Maternal weight gain 
(lbs) (SD) 
14.58 
(11.46)
16.14 
(10.85)
0.385
Hypertension (%) 3 (3.53%) 7 (9.33%) 0.297
Pre-eclampsia (%) 6 (7.06%) 6 (8.00%) 0.874
Maternal glycemic 
values fasting 
(mg/dL) (SD)
90.67 
(12.19(
99.17 
(10.97)
<0.001*
Maternal glycemic
values 2 hr PP 
breakfast (mg/dL) 
(SD)
108.78 
(13.63)
116.11 
(13.47)
0.001*
Maternal glycemic 
values 2 hr PP 
dinner (mg/dL) (SD)
117.07 
(14.33)
112.95 
(16.65)
0.02
A1c at end (%) (SD) 5.55 (0.46) 6.47 (1.79) <0.001*
Fetal Outcomes Group 1 (Diet 
Only) (85)
Group 2 (Diet + 
Insulin) (75)
P - value
Large for 
Gestational Age  
(%) 
1 (1.18%) 5 (6.67%) 0.07
Macrosomia (%) 1 (1.18%) 5 (6.67%) 0.07
Birth weight (gm) 
(SD)
3346 (541) 3487 (716) 0.18
Apgar score at 5 
minutes (SD)
8.94 (0.29) 8.70 (0.92) 0.41
Hypoglycemia (%) 0 (0%) 0 (0%) -
Premature birth (%) 7 (8.24%) 11 (14.67%) 0.25
Neonatal jaundice 
(%)
0 (0%) 0 (0%) -
Dystocia (%) 2 (2.35%) 3 (4.00%) 0.30
No  
• Baseline characteristics
• Patient age and  gestational age at diagnosis were 
similar in patients in both groups.
• A1c and BMI at initial visit was statistically significant 
between two groups. 
• Diet + insulin group had a significantly higher A1c  
and BMI at initial visit as compared to diet only.  
• Patients with higher A1c values and BMI will 
require insulin as compared to those with lower 
A1c and BMI initially.
• Maternal Outcomes
• Rates of caesarean  delivery, maternal weight gain, 
hypertension, pre-eclampsia were similar for both 
groups.
• As with the initial A1c, statistical significance was 
found in A1c at end of pregnancy  with significantly 
higher A1c in diet + insulin group. 
• Maternal glycemic control
• Fasting, and 2 hr breakfast glycemic values were 
statistically significant between the two treatment 
groups.
• Significantly higher values in the diet + insulin 
group. 
• 2 hour post prandial dinner glycemic control did  
not quite achieve statistical difference. 
• Fetal Outcomes
• Neonatal hypoglycemia and jaundice did not occur in 
either group. 
• Large for gestational age, macrosomia, Apgar score 
at 5 minutes, birth weight and premature birth were 
similar in both groups.
• Apgar score at 5 minutes trended lower in diet + 
insulin
• Overall
• Maternal outcomes that had significant differences in 
this smaller sample size were
• A1c and BMI at initial visit  
• A1c at end of pregnancy
• Maternal fasting, and 2 hr PP breakfast  glycemic 
values
• Fetal outcome s were similar whether treated with  
diet alone or diet + insulin.
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